The European Federation for Exploratory Medicines Development – EUFEMED – was founded in 2015 as a result of an ongoing, informal collaboration between several European societies active in the area of human pharmacology.
EUFEMED has been recognized as a stakeholder by EMA and is consulted for the revision of important European regulations and guidelines related to clinical drug development.
EUFEMED is a not for profit association established under the Belgian law.
In order to strengthen the voice of EUFEMED and in the importance of early medicines development in Europe, other societies and additional countries are invited to become members.
Join us!
Become a full member or an associate member of EUFEMED and profit from the advantages!
About us
EUFEMED represents national and European federations, organisations or associations active in early clinical medicines development.
Based on the successful collaborations since 2007 between our members, their comparable objectives and the growing importance of early clinical drug development EUFEMED strives to be a “voice” in the interest of exploratory medicines development in Europe.
EUFEMED promotes the interest of early clinical medicines development in professional organisations, international organisations and public authorities.
Our aims are to help the members in all professional fields, organise meetings and conferences, courses and specialist training, and much more… We develop standards and promote guidance documents in early medicines development in order to improve European competitiveness.
Upcoming events
19-Oct-2017: EUFEMED 2017 Delegate Feedback Report ...
Methodology Conference attendees (n=214, excluding exhibitors) were sent a link to a web-based questionnaire by email following the close of the meeting. Feedback was collected anonymously. General Questions (n=55) (n=53)… Read More ...01-Dec-2017: Promoting Safe Early Clinical Research of Novel Drug ...
A commentary on the revision of the first-in-human guidelines has been published in Clinical Pharmacology and Therapeutics. It is available at wiley.com (open access). The overviews of comments received during… Read More ...18-Jan-2018 – Conference Summary for the EUFEMED conference, ...
...27th AGAH Annual Meeting 2018 ...
...
Get in touch
If you are interested in working together, send us an inquiry and we will get back to you as soon as we can!
Contact us